Records containing: Ovarian Clear Cell Carcinoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-03-18
A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-doublet Chemotherapy and Bevacizumab Compared With Physician's Choice of Chemotherapy and Bevacizumab in Women With Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
CLINICAL_TRIALS study record update · 2025-12-24
Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
CLINICAL_TRIALS study record update · 2025-12-16
A Phase II Trial of Pembrolizumab and Lenvatinib in Patients With Recurrent or Persistent Clear Cell Carcinoma of the Ovary
CLINICAL_TRIALS study record update · 2025-11-20
Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma: A Multicenter, Single-Arm, Phase II Clinical Study
CLINICAL_TRIALS study record update · 2025-08-08
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-06-03
Randomized Active-controlled Trial Evaluating QL1706 Plus Bevacizumab Versus Platinum-Based Chemotherapy for Advanced First-Line Ovarian Clear Cell Carcinoma
CLINICAL_TRIALS study record update · 2025-05-15
A Phase 1/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
CLINICAL_TRIALS study record update · 2024-09-04
Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing: A-TRAIN
CLINICAL_TRIALS study record update · 2024-08-13
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
CLINICAL_TRIALS study record update · 2024-08-13
Sintilimab Plus Bevacizumab in Patients With Recurrent/Persistent Ovarian Clear Cell Carcinoma
CLINICAL_TRIALS study record update · 2023-10-19
First-in-Human, Phase 1 Study of AMT-151, an Anti-Folate Receptor Alpha Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
CLINICAL_TRIALS study record update · 2023-03-08
Zimberelimab Combined With Metformin in the Treatment of Recurrent Ovarian Clear Cell Carcinoma: A Pilot Study
CLINICAL_TRIALS study record update · 2022-11-16
A Phase I Study of Safety, Pharmacokinetic and Efficacy of Orally Administered APG-5918 in Patients With Advanced Solid Tumors or Hematologic Malignancies
CLINICAL_TRIALS study record update · 2022-11-01
Exploratory Clinical Study of Camrelizumab in Combination With Anlotinib in the Treatment of Patients With Advanced Ovarian Clear Cell Carcinoma
CLINICAL_TRIALS study record update · 2022-07-25
A Phase 1b Dose-escalation Study to Assess Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLX2853 in Subjects With Advanced Malignancies
CLINICAL_TRIALS study record update · 2020-06-04
A Phase l Open-Label, Dose Escalation and Cohort Expansion Study, to Assess the Safety and Activity of the Antibody-Drug Conjugate CDX-014 in Advanced or Metastatic Renal Cell Carcinoma (RCC) and Advanced or Metastatic Ovarian Clear Cell Carcinoma (OCCC)
CLINICAL_TRIALS study record update · 2019-12-13
Phase II Study of Oral ENMD-2076 Administered to Patients With Ovarian Clear Cell Carcinomas
CLINICAL_TRIALS study record update · 2018-05-18
A Multicentre Phase II Randomised Trial of Durvalumab (MEDI4736) Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas (MOCCA)
CLINICAL_TRIALS study record update · 2016-08-15
A Randomised Phase II Study Of Nintedanib (BIBF1120) Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium